Dr Sezelle Gereau, MD | |
Sezelle Gereau Inc, 33 Daffodil Hill Road, Garrison, NY 10524 | |
(347) 680-7085 | |
(646) 935-2272 |
Full Name | Dr Sezelle Gereau |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Location | Sezelle Gereau Inc, Garrison, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649389701 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 153392 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Sezelle Gereau, MD 33 Daffodil Hill Road, Garrison, NY 10524 Ph: (347) 680-7085 | Dr Sezelle Gereau, MD Sezelle Gereau Inc, 33 Daffodil Hill Road, Garrison, NY 10524 Ph: (347) 680-7085 |
News Archive
A supplemental "boost" of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with Ductal Carcinoma In Situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
As the rate of thyroid cancer continues to climb, doctors are urging patients to be more cautious about thyroid nodules, a common disorder that is responsible for a small but growing number of thyroid cancer cases.
HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using High Intensity Focused Ultrasound ("HIFU"), announces groundbreaking partnerships with Michael J. Lazar, MD in Santa Rosa, Calif. and John H. Jurige, MD in Louisville, Ky., to offer HIFU treatments for prostate cancer.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today presented updated clinical data from its Phase I/II study of lead product candidate VAL-083 (dianhydrogalactitol), in patients with refractory glioblastoma multiforme (GBM), at GBM2015: 2nd International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain.
› Verified 8 days ago